Robert W. Hesslein

Insider Reports History

Location
Cambridge, MA
Signature
By: Brett Budzinski, Attorney-in-Fact For: Robert W. Hesslein
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Robert W. Hesslein:

Company Role Class Num Shares Value Price $ Report Date Ownership
ALNYLAM PHARMACEUTICALS, INC. EVP, CLO and Secretary Common Stock 8,002 $1,943,926 $242.93 03 Mar 2025 Direct
Voyager Therapeutics, Inc. Senior VP & General Counsel Common Stock 102,200 $730,730 $7.15 20 Mar 2023 Direct
ALNYLAM PHARMACEUTICALS, INC. EVP, CLO and Secretary Stock Option (right to buy) 1,529 03 Mar 2025 Direct

Insider Reports Filed by Robert W. Hesslein

Symbol Company Period Transactions Value $ Form Type Role Filing Time
ALNY ALNYLAM PHARMACEUTICALS, INC. 03 Mar 2025 2 $0 4 EVP, CLO and Secretary 05 Mar 2025, 16:23
ALNY ALNYLAM PHARMACEUTICALS, INC. 01 Oct 2024 1 $0 4 EVP, CLO and Secretary 03 Oct 2024, 16:11
ALNY ALNYLAM PHARMACEUTICALS, INC. 30 Sep 2024 0 $0 3 EVP, CLO and Secretary 03 Oct 2024, 16:08
VYGR Voyager Therapeutics, Inc. 20 Mar 2023 1 -$34,221 4 Senior VP & General Counsel 22 Mar 2023, 16:47
VYGR Voyager Therapeutics, Inc. 17 Feb 2023 1 -$24,562 4 Senior VP & General Counsel 22 Feb 2023, 19:58
VYGR Voyager Therapeutics, Inc. 13 Feb 2023 1 -$21,997 4 Senior VP & General Counsel 15 Feb 2023, 15:52
VYGR Voyager Therapeutics, Inc. 17 Jan 2023 2 -$21,549 4 Senior VP & General Counsel 19 Jan 2023, 15:57
VYGR Voyager Therapeutics, Inc. 04 Apr 2022 1 -$22,984 4 Senior VP & General Counsel 06 Apr 2022, 16:34
VYGR Voyager Therapeutics, Inc. 21 Mar 2022 2 -$41,099 4 Senior VP & General Counsel 23 Mar 2022, 18:39
VYGR Voyager Therapeutics, Inc. 17 Feb 2022 1 -$14,555 4 Senior VP & General Counsel 22 Feb 2022, 15:37
VYGR Voyager Therapeutics, Inc. 11 Feb 2022 1 -$10,926 4 Senior VP & General Counsel 15 Feb 2022, 15:42
VYGR Voyager Therapeutics, Inc. 13 Jan 2022 2 $0 4 Senior VP & General Counsel 18 Jan 2022, 19:06